Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / May / AI: We Owe it to the Patients
Opinion and Personal Narratives Digital Pathology Voices in the Community Bioinformatics Clinical care Technology and innovation

AI: We Owe it to the Patients

Among the many benefits of AI technologies, the most important is better patient outcomes, says Rajendra Singh

By Rajendra Singh 05/05/2025 Opinion 2 min read

Share

Rajendra Singh

Artificial Intelligence (AI) is redefining the landscape of pathology through cutting-edge advancements in image analysis, data interpretation, and report generation. These technologies are enabling unprecedented accuracy and efficiency in diagnostics – allowing more patients to receive their test results more quickly, while minimizing diagnostic disparities.

But improved turnaround times are just the tip of the iceberg in terms of AI-augmented pathology. To truly deliver personalized medicine, we must integrate AI tools that go beyond diagnostics, enhancing every stage of a patient’s journey toward recovery.

AI can predict underlying molecular changes in disease by correlating histopathological data with genomic and proteomic profiles. This enables clinicians to identify actionable biomarkers and make informed decisions regarding targeted therapies. AI-powered companion diagnostic tests match patients to the best available drugs for their disease variant, ensuring personalized treatment plans.

Prognostics are also being advanced by machine learning. AI models can be trained to predict the progress of diseases, helping the clinician to have a more informed discussion about outcomes.

And in research, by efficiently matching patients to clinical trials for companion diagnostics, AI opens doors to early and more specific treatments and therapies. During trials, AI tools can also monitor patient responses, providing real-time insights to researchers and clinicians.

The drawback is that these tools do not come cheap. Healthcare data is not collected or available in a manner that makes it usable out of the box. Preparing the data to be suitable for training models needs public–private partnerships to ensure diversity and availability, huge computational infrastructure for training and validation, and a physician workforce that is trained to use the models appropriately. 

We are at the cusp of a transformative era in healthcare. AI models have already demonstrated their potential to significantly enhance the work of clinicians. As these models continue to evolve and improve, it is our responsibility as clinicians to ensure they are inclusive and equitable, enabling every patient to access personalized treatment and achieve better outcomes. 

The basis of all these models is data generated in the pathology department and, by embracing these innovations thoughtfully and rigorously, pathology can truly emerge as a cornerstone of cognitive excellence in medicine.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Rajendra Singh

Co-Founder, PathPresenter, and Director of Dermatopathology and Digital Pathology, Summit Health

More Articles by Rajendra Singh

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Opinion and Personal Narratives
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

qPCR Infectious Disease Detective
Opinion and Personal Narratives
qPCR: Infectious Disease Detective

January 4, 2024

3 min read

How quantitative polymerase chain reaction really hits the mark in epidemic control and ID detection

The Transformative Power of Patient Advocacy
Opinion and Personal Narratives
The Transformative Power of Patient Advocacy

January 24, 2024

3 min read

Michele Mitchell shares her personal journey into patient advocacy

Byte the Bias
Opinion and Personal Narratives
Byte the Bias

January 11, 2024

1 min read

How does artificial intelligence view a pathologist?

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.